Oral Anti-Diabetic Drug Market, Global Outlook and Forecast 2022-2028
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
This report contains market size and forecasts of Oral Anti-Diabetic Drug in global, including the following market information:
Global Oral Anti-Diabetic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Anti-Diabetic Drug Market Sales, 2017-2022, 2023-2028, (K Tons)
Global top five Oral Anti-Diabetic Drug companies in 2021 (%)
The global Oral Anti-Diabetic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glimepiride Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Anti-Diabetic Drug include Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck And Co., AstraZeneca and Bristol Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Anti-Diabetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Anti-Diabetic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Oral Anti-Diabetic Drug Market Segment Percentages, by Type, 2021 (%)
Global Oral Anti-Diabetic Drug Market Segment Percentages, by Application, 2021 (%)
Global Oral Anti-Diabetic Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Oral Anti-Diabetic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Anti-Diabetic Drug revenues share in global market, 2021 (%)
Key companies Oral Anti-Diabetic Drug sales in global market, 2017-2022 (Estimated), (K Tons)
Key companies Oral Anti-Diabetic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Oral Anti-Diabetic Drug in global, including the following market information:
Global Oral Anti-Diabetic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Anti-Diabetic Drug Market Sales, 2017-2022, 2023-2028, (K Tons)
Global top five Oral Anti-Diabetic Drug companies in 2021 (%)
The global Oral Anti-Diabetic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glimepiride Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Anti-Diabetic Drug include Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck And Co., AstraZeneca and Bristol Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Anti-Diabetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Anti-Diabetic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Oral Anti-Diabetic Drug Market Segment Percentages, by Type, 2021 (%)
- Glimepiride
- Gliclazide
- Glyburide
- Others
Global Oral Anti-Diabetic Drug Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Research Institual
Global Oral Anti-Diabetic Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Oral Anti-Diabetic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Anti-Diabetic Drug revenues share in global market, 2021 (%)
Key companies Oral Anti-Diabetic Drug sales in global market, 2017-2022 (Estimated), (K Tons)
Key companies Oral Anti-Diabetic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda
- Pfizer
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- Merck And Co.
- AstraZeneca
- Bristol Myers Squibb
- Novartis
- Sanofi
- Abbott
- Biocon
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Oral Anti-Diabetic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Anti-Diabetic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ORAL ANTI-DIABETIC DRUG OVERALL MARKET SIZE
2.1 Global Oral Anti-Diabetic Drug Market Size: 2021 VS 2028
2.2 Global Oral Anti-Diabetic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oral Anti-Diabetic Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Oral Anti-Diabetic Drug Players in Global Market
3.2 Top Global Oral Anti-Diabetic Drug Companies Ranked by Revenue
3.3 Global Oral Anti-Diabetic Drug Revenue by Companies
3.4 Global Oral Anti-Diabetic Drug Sales by Companies
3.5 Global Oral Anti-Diabetic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oral Anti-Diabetic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oral Anti-Diabetic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Anti-Diabetic Drug Players in Global Market
3.8.1 List of Global Tier 1 Oral Anti-Diabetic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Anti-Diabetic Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Oral Anti-Diabetic Drug Market Size Markets, 2021 & 2028
4.1.2 Glimepiride
4.1.3 Gliclazide
4.1.4 Glyburide
4.1.5 Others
4.2 By Type - Global Oral Anti-Diabetic Drug Revenue & Forecasts
4.2.1 By Type - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
4.2.2 By Type - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
4.2.3 By Type - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Oral Anti-Diabetic Drug Sales & Forecasts
4.3.1 By Type - Global Oral Anti-Diabetic Drug Sales, 2017-2022
4.3.2 By Type - Global Oral Anti-Diabetic Drug Sales, 2023-2028
4.3.3 By Type - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Oral Anti-Diabetic Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Oral Anti-Diabetic Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Research Institual
5.2 By Application - Global Oral Anti-Diabetic Drug Revenue & Forecasts
5.2.1 By Application - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
5.2.2 By Application - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
5.2.3 By Application - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Oral Anti-Diabetic Drug Sales & Forecasts
5.3.1 By Application - Global Oral Anti-Diabetic Drug Sales, 2017-2022
5.3.2 By Application - Global Oral Anti-Diabetic Drug Sales, 2023-2028
5.3.3 By Application - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Oral Anti-Diabetic Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Oral Anti-Diabetic Drug Market Size, 2021 & 2028
6.2 By Region - Global Oral Anti-Diabetic Drug Revenue & Forecasts
6.2.1 By Region - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
6.2.2 By Region - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
6.2.3 By Region - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Oral Anti-Diabetic Drug Sales & Forecasts
6.3.1 By Region - Global Oral Anti-Diabetic Drug Sales, 2017-2022
6.3.2 By Region - Global Oral Anti-Diabetic Drug Sales, 2023-2028
6.3.3 By Region - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Oral Anti-Diabetic Drug Revenue, 2017-2028
6.4.2 By Country - North America Oral Anti-Diabetic Drug Sales, 2017-2028
6.4.3 US Oral Anti-Diabetic Drug Market Size, 2017-2028
6.4.4 Canada Oral Anti-Diabetic Drug Market Size, 2017-2028
6.4.5 Mexico Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Oral Anti-Diabetic Drug Revenue, 2017-2028
6.5.2 By Country - Europe Oral Anti-Diabetic Drug Sales, 2017-2028
6.5.3 Germany Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.4 France Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.5 U.K. Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.6 Italy Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.7 Russia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.8 Nordic Countries Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.9 Benelux Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Oral Anti-Diabetic Drug Revenue, 2017-2028
6.6.2 By Region - Asia Oral Anti-Diabetic Drug Sales, 2017-2028
6.6.3 China Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.4 Japan Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.5 South Korea Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.6 Southeast Asia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.7 India Oral Anti-Diabetic Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Oral Anti-Diabetic Drug Revenue, 2017-2028
6.7.2 By Country - South America Oral Anti-Diabetic Drug Sales, 2017-2028
6.7.3 Brazil Oral Anti-Diabetic Drug Market Size, 2017-2028
6.7.4 Argentina Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, 2017-2028
6.8.3 Turkey Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.4 Israel Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.6 UAE Oral Anti-Diabetic Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Oral Anti-Diabetic Drug Major Product Offerings
7.1.4 Takeda Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Oral Anti-Diabetic Drug Major Product Offerings
7.2.4 Pfizer Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Oral Anti-Diabetic Drug Major Product Offerings
7.3.4 Eli Lilly Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Corporate Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Major Product Offerings
7.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.4.5 Janssen Pharmaceuticals Key News
7.5 Astellas
7.5.1 Astellas Corporate Summary
7.5.2 Astellas Business Overview
7.5.3 Astellas Oral Anti-Diabetic Drug Major Product Offerings
7.5.4 Astellas Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.5.5 Astellas Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Major Product Offerings
7.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Merck And Co.
7.7.1 Merck And Co. Corporate Summary
7.7.2 Merck And Co. Business Overview
7.7.3 Merck And Co. Oral Anti-Diabetic Drug Major Product Offerings
7.7.4 Merck And Co. Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.7.5 Merck And Co. Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Oral Anti-Diabetic Drug Major Product Offerings
7.8.4 AstraZeneca Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca Key News
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Corporate Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Major Product Offerings
7.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.9.5 Bristol Myers Squibb Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Oral Anti-Diabetic Drug Major Product Offerings
7.10.4 Novartis Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Sanofi
7.11.1 Sanofi Corporate Summary
7.11.2 Sanofi Oral Anti-Diabetic Drug Business Overview
7.11.3 Sanofi Oral Anti-Diabetic Drug Major Product Offerings
7.11.4 Sanofi Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.11.5 Sanofi Key News
7.12 Abbott
7.12.1 Abbott Corporate Summary
7.12.2 Abbott Oral Anti-Diabetic Drug Business Overview
7.12.3 Abbott Oral Anti-Diabetic Drug Major Product Offerings
7.12.4 Abbott Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.12.5 Abbott Key News
7.13 Biocon
7.13.1 Biocon Corporate Summary
7.13.2 Biocon Oral Anti-Diabetic Drug Business Overview
7.13.3 Biocon Oral Anti-Diabetic Drug Major Product Offerings
7.13.4 Biocon Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.13.5 Biocon Key News
8 GLOBAL ORAL ANTI-DIABETIC DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Oral Anti-Diabetic Drug Production Capacity, 2017-2028
8.2 Oral Anti-Diabetic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Anti-Diabetic Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ORAL ANTI-DIABETIC DRUG SUPPLY CHAIN ANALYSIS
10.1 Oral Anti-Diabetic Drug Industry Value Chain
10.2 Oral Anti-Diabetic Drug Upstream Market
10.3 Oral Anti-Diabetic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Anti-Diabetic Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Oral Anti-Diabetic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Anti-Diabetic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ORAL ANTI-DIABETIC DRUG OVERALL MARKET SIZE
2.1 Global Oral Anti-Diabetic Drug Market Size: 2021 VS 2028
2.2 Global Oral Anti-Diabetic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oral Anti-Diabetic Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Oral Anti-Diabetic Drug Players in Global Market
3.2 Top Global Oral Anti-Diabetic Drug Companies Ranked by Revenue
3.3 Global Oral Anti-Diabetic Drug Revenue by Companies
3.4 Global Oral Anti-Diabetic Drug Sales by Companies
3.5 Global Oral Anti-Diabetic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oral Anti-Diabetic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oral Anti-Diabetic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Anti-Diabetic Drug Players in Global Market
3.8.1 List of Global Tier 1 Oral Anti-Diabetic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Anti-Diabetic Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Oral Anti-Diabetic Drug Market Size Markets, 2021 & 2028
4.1.2 Glimepiride
4.1.3 Gliclazide
4.1.4 Glyburide
4.1.5 Others
4.2 By Type - Global Oral Anti-Diabetic Drug Revenue & Forecasts
4.2.1 By Type - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
4.2.2 By Type - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
4.2.3 By Type - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Oral Anti-Diabetic Drug Sales & Forecasts
4.3.1 By Type - Global Oral Anti-Diabetic Drug Sales, 2017-2022
4.3.2 By Type - Global Oral Anti-Diabetic Drug Sales, 2023-2028
4.3.3 By Type - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Oral Anti-Diabetic Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Oral Anti-Diabetic Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Research Institual
5.2 By Application - Global Oral Anti-Diabetic Drug Revenue & Forecasts
5.2.1 By Application - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
5.2.2 By Application - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
5.2.3 By Application - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Oral Anti-Diabetic Drug Sales & Forecasts
5.3.1 By Application - Global Oral Anti-Diabetic Drug Sales, 2017-2022
5.3.2 By Application - Global Oral Anti-Diabetic Drug Sales, 2023-2028
5.3.3 By Application - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Oral Anti-Diabetic Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Oral Anti-Diabetic Drug Market Size, 2021 & 2028
6.2 By Region - Global Oral Anti-Diabetic Drug Revenue & Forecasts
6.2.1 By Region - Global Oral Anti-Diabetic Drug Revenue, 2017-2022
6.2.2 By Region - Global Oral Anti-Diabetic Drug Revenue, 2023-2028
6.2.3 By Region - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Oral Anti-Diabetic Drug Sales & Forecasts
6.3.1 By Region - Global Oral Anti-Diabetic Drug Sales, 2017-2022
6.3.2 By Region - Global Oral Anti-Diabetic Drug Sales, 2023-2028
6.3.3 By Region - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Oral Anti-Diabetic Drug Revenue, 2017-2028
6.4.2 By Country - North America Oral Anti-Diabetic Drug Sales, 2017-2028
6.4.3 US Oral Anti-Diabetic Drug Market Size, 2017-2028
6.4.4 Canada Oral Anti-Diabetic Drug Market Size, 2017-2028
6.4.5 Mexico Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Oral Anti-Diabetic Drug Revenue, 2017-2028
6.5.2 By Country - Europe Oral Anti-Diabetic Drug Sales, 2017-2028
6.5.3 Germany Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.4 France Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.5 U.K. Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.6 Italy Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.7 Russia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.8 Nordic Countries Oral Anti-Diabetic Drug Market Size, 2017-2028
6.5.9 Benelux Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Oral Anti-Diabetic Drug Revenue, 2017-2028
6.6.2 By Region - Asia Oral Anti-Diabetic Drug Sales, 2017-2028
6.6.3 China Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.4 Japan Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.5 South Korea Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.6 Southeast Asia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.6.7 India Oral Anti-Diabetic Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Oral Anti-Diabetic Drug Revenue, 2017-2028
6.7.2 By Country - South America Oral Anti-Diabetic Drug Sales, 2017-2028
6.7.3 Brazil Oral Anti-Diabetic Drug Market Size, 2017-2028
6.7.4 Argentina Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, 2017-2028
6.8.3 Turkey Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.4 Israel Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Oral Anti-Diabetic Drug Market Size, 2017-2028
6.8.6 UAE Oral Anti-Diabetic Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Oral Anti-Diabetic Drug Major Product Offerings
7.1.4 Takeda Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Oral Anti-Diabetic Drug Major Product Offerings
7.2.4 Pfizer Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Oral Anti-Diabetic Drug Major Product Offerings
7.3.4 Eli Lilly Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Corporate Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Major Product Offerings
7.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.4.5 Janssen Pharmaceuticals Key News
7.5 Astellas
7.5.1 Astellas Corporate Summary
7.5.2 Astellas Business Overview
7.5.3 Astellas Oral Anti-Diabetic Drug Major Product Offerings
7.5.4 Astellas Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.5.5 Astellas Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Major Product Offerings
7.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Merck And Co.
7.7.1 Merck And Co. Corporate Summary
7.7.2 Merck And Co. Business Overview
7.7.3 Merck And Co. Oral Anti-Diabetic Drug Major Product Offerings
7.7.4 Merck And Co. Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.7.5 Merck And Co. Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Oral Anti-Diabetic Drug Major Product Offerings
7.8.4 AstraZeneca Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.8.5 AstraZeneca Key News
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Corporate Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Major Product Offerings
7.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.9.5 Bristol Myers Squibb Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Oral Anti-Diabetic Drug Major Product Offerings
7.10.4 Novartis Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Sanofi
7.11.1 Sanofi Corporate Summary
7.11.2 Sanofi Oral Anti-Diabetic Drug Business Overview
7.11.3 Sanofi Oral Anti-Diabetic Drug Major Product Offerings
7.11.4 Sanofi Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.11.5 Sanofi Key News
7.12 Abbott
7.12.1 Abbott Corporate Summary
7.12.2 Abbott Oral Anti-Diabetic Drug Business Overview
7.12.3 Abbott Oral Anti-Diabetic Drug Major Product Offerings
7.12.4 Abbott Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.12.5 Abbott Key News
7.13 Biocon
7.13.1 Biocon Corporate Summary
7.13.2 Biocon Oral Anti-Diabetic Drug Business Overview
7.13.3 Biocon Oral Anti-Diabetic Drug Major Product Offerings
7.13.4 Biocon Oral Anti-Diabetic Drug Sales and Revenue in Global (2017-2022)
7.13.5 Biocon Key News
8 GLOBAL ORAL ANTI-DIABETIC DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Oral Anti-Diabetic Drug Production Capacity, 2017-2028
8.2 Oral Anti-Diabetic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Anti-Diabetic Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ORAL ANTI-DIABETIC DRUG SUPPLY CHAIN ANALYSIS
10.1 Oral Anti-Diabetic Drug Industry Value Chain
10.2 Oral Anti-Diabetic Drug Upstream Market
10.3 Oral Anti-Diabetic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Anti-Diabetic Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Oral Anti-Diabetic Drug in Global Market
Table 2. Top Oral Anti-Diabetic Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oral Anti-Diabetic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oral Anti-Diabetic Drug Revenue Share by Companies, 2017-2022
Table 5. Global Oral Anti-Diabetic Drug Sales by Companies, (K Tons), 2017-2022
Table 6. Global Oral Anti-Diabetic Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oral Anti-Diabetic Drug Price (2017-2022) & (USD/Ton)
Table 8. Global Manufacturers Oral Anti-Diabetic Drug Product Type
Table 9. List of Global Tier 1 Oral Anti-Diabetic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Anti-Diabetic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 15. By Type - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 16. By Application – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 20. By Application - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 21. By Region – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 25. By Region - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 26. By Country - North America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 29. By Country - North America Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 30. By Country - Europe Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 33. By Country - Europe Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 34. By Region - Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 37. By Region - Asia Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 38. By Country - South America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 41. By Country - South America Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 42. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 45. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 46. Takeda Corporate Summary
Table 47. Takeda Oral Anti-Diabetic Drug Product Offerings
Table 48. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Oral Anti-Diabetic Drug Product Offerings
Table 51. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 52. Eli Lilly Corporate Summary
Table 53. Eli Lilly Oral Anti-Diabetic Drug Product Offerings
Table 54. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 55. Janssen Pharmaceuticals Corporate Summary
Table 56. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Offerings
Table 57. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 58. Astellas Corporate Summary
Table 59. Astellas Oral Anti-Diabetic Drug Product Offerings
Table 60. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Offerings
Table 63. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 64. Merck And Co. Corporate Summary
Table 65. Merck And Co. Oral Anti-Diabetic Drug Product Offerings
Table 66. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 67. AstraZeneca Corporate Summary
Table 68. AstraZeneca Oral Anti-Diabetic Drug Product Offerings
Table 69. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 70. Bristol Myers Squibb Corporate Summary
Table 71. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Offerings
Table 72. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Oral Anti-Diabetic Drug Product Offerings
Table 75. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 76. Sanofi Corporate Summary
Table 77. Sanofi Oral Anti-Diabetic Drug Product Offerings
Table 78. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 79. Abbott Corporate Summary
Table 80. Abbott Oral Anti-Diabetic Drug Product Offerings
Table 81. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 82. Biocon Corporate Summary
Table 83. Biocon Oral Anti-Diabetic Drug Product Offerings
Table 84. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 85. Oral Anti-Diabetic Drug Production Capacity (K Tons) of Key Manufacturers in Global Market, 2020-2022 (K Tons)
Table 86. Global Oral Anti-Diabetic Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Oral Anti-Diabetic Drug Production by Region, 2017-2022 (K Tons)
Table 88. Global Oral Anti-Diabetic Drug Production by Region, 2023-2028 (K Tons)
Table 89. Oral Anti-Diabetic Drug Market Opportunities & Trends in Global Market
Table 90. Oral Anti-Diabetic Drug Market Drivers in Global Market
Table 91. Oral Anti-Diabetic Drug Market Restraints in Global Market
Table 92. Oral Anti-Diabetic Drug Raw Materials
Table 93. Oral Anti-Diabetic Drug Raw Materials Suppliers in Global Market
Table 94. Typical Oral Anti-Diabetic Drug Downstream
Table 95. Oral Anti-Diabetic Drug Downstream Clients in Global Market
Table 96. Oral Anti-Diabetic Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of Oral Anti-Diabetic Drug in Global Market
Table 2. Top Oral Anti-Diabetic Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oral Anti-Diabetic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oral Anti-Diabetic Drug Revenue Share by Companies, 2017-2022
Table 5. Global Oral Anti-Diabetic Drug Sales by Companies, (K Tons), 2017-2022
Table 6. Global Oral Anti-Diabetic Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oral Anti-Diabetic Drug Price (2017-2022) & (USD/Ton)
Table 8. Global Manufacturers Oral Anti-Diabetic Drug Product Type
Table 9. List of Global Tier 1 Oral Anti-Diabetic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Anti-Diabetic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 15. By Type - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 16. By Application – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 20. By Application - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 21. By Region – Global Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oral Anti-Diabetic Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oral Anti-Diabetic Drug Sales (K Tons), 2017-2022
Table 25. By Region - Global Oral Anti-Diabetic Drug Sales (K Tons), 2023-2028
Table 26. By Country - North America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 29. By Country - North America Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 30. By Country - Europe Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 33. By Country - Europe Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 34. By Region - Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 37. By Region - Asia Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 38. By Country - South America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 41. By Country - South America Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 42. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, (K Tons), 2017-2022
Table 45. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales, (K Tons), 2023-2028
Table 46. Takeda Corporate Summary
Table 47. Takeda Oral Anti-Diabetic Drug Product Offerings
Table 48. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Oral Anti-Diabetic Drug Product Offerings
Table 51. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 52. Eli Lilly Corporate Summary
Table 53. Eli Lilly Oral Anti-Diabetic Drug Product Offerings
Table 54. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 55. Janssen Pharmaceuticals Corporate Summary
Table 56. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Offerings
Table 57. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 58. Astellas Corporate Summary
Table 59. Astellas Oral Anti-Diabetic Drug Product Offerings
Table 60. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Offerings
Table 63. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 64. Merck And Co. Corporate Summary
Table 65. Merck And Co. Oral Anti-Diabetic Drug Product Offerings
Table 66. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 67. AstraZeneca Corporate Summary
Table 68. AstraZeneca Oral Anti-Diabetic Drug Product Offerings
Table 69. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 70. Bristol Myers Squibb Corporate Summary
Table 71. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Offerings
Table 72. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Oral Anti-Diabetic Drug Product Offerings
Table 75. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 76. Sanofi Corporate Summary
Table 77. Sanofi Oral Anti-Diabetic Drug Product Offerings
Table 78. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 79. Abbott Corporate Summary
Table 80. Abbott Oral Anti-Diabetic Drug Product Offerings
Table 81. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 82. Biocon Corporate Summary
Table 83. Biocon Oral Anti-Diabetic Drug Product Offerings
Table 84. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 85. Oral Anti-Diabetic Drug Production Capacity (K Tons) of Key Manufacturers in Global Market, 2020-2022 (K Tons)
Table 86. Global Oral Anti-Diabetic Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Oral Anti-Diabetic Drug Production by Region, 2017-2022 (K Tons)
Table 88. Global Oral Anti-Diabetic Drug Production by Region, 2023-2028 (K Tons)
Table 89. Oral Anti-Diabetic Drug Market Opportunities & Trends in Global Market
Table 90. Oral Anti-Diabetic Drug Market Drivers in Global Market
Table 91. Oral Anti-Diabetic Drug Market Restraints in Global Market
Table 92. Oral Anti-Diabetic Drug Raw Materials
Table 93. Oral Anti-Diabetic Drug Raw Materials Suppliers in Global Market
Table 94. Typical Oral Anti-Diabetic Drug Downstream
Table 95. Oral Anti-Diabetic Drug Downstream Clients in Global Market
Table 96. Oral Anti-Diabetic Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Oral Anti-Diabetic Drug Segment by Type
Figure 2. Oral Anti-Diabetic Drug Segment by Application
Figure 3. Global Oral Anti-Diabetic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral Anti-Diabetic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral Anti-Diabetic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Oral Anti-Diabetic Drug Sales in Global Market: 2017-2028 (K Tons)
Figure 8. The Top 3 and 5 Players Market Share by Oral Anti-Diabetic Drug Revenue in 2021
Figure 9. By Type - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oral Anti-Diabetic Drug Price (USD/Ton), 2017-2028
Figure 12. By Application - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oral Anti-Diabetic Drug Price (USD/Ton), 2017-2028
Figure 15. By Region - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 19. US Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 24. Germany Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 33. China Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 40. Brazil Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 44. Turkey Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oral Anti-Diabetic Drug Production Capacity (K Tons), 2017-2028
Figure 49. The Percentage of Production Oral Anti-Diabetic Drug by Region, 2021 VS 2028
Figure 50. Oral Anti-Diabetic Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Oral Anti-Diabetic Drug Segment by Type
Figure 2. Oral Anti-Diabetic Drug Segment by Application
Figure 3. Global Oral Anti-Diabetic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral Anti-Diabetic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral Anti-Diabetic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Oral Anti-Diabetic Drug Sales in Global Market: 2017-2028 (K Tons)
Figure 8. The Top 3 and 5 Players Market Share by Oral Anti-Diabetic Drug Revenue in 2021
Figure 9. By Type - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oral Anti-Diabetic Drug Price (USD/Ton), 2017-2028
Figure 12. By Application - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oral Anti-Diabetic Drug Price (USD/Ton), 2017-2028
Figure 15. By Region - Global Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 19. US Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 24. Germany Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 33. China Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 40. Brazil Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share, 2017-2028
Figure 44. Turkey Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oral Anti-Diabetic Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oral Anti-Diabetic Drug Production Capacity (K Tons), 2017-2028
Figure 49. The Percentage of Production Oral Anti-Diabetic Drug by Region, 2021 VS 2028
Figure 50. Oral Anti-Diabetic Drug Industry Value Chain
Figure 51. Marketing Channels
